Technology solutions that shape the future

Technology solutions that shape the future

Identifying, supporting, patenting and marketing technical innovation by harvesting top technology talent to bring game-changing product to the market.

Nanotechnology and medicine

Nanotechnology and medicine

In the fight against cancer, nanotechnology introduces unique approaches to diagnosis and treatment that could not even be imagined with conventional technology.

Understanding Nanotechnology

Understanding Nanotechnology

Nanotechnology is the development and engineering of devices so small that they are measured on a molecular scale.

Early disease detection

Early disease detection

Dr. Edward Flynn has developed a nanotechnology-based, magnetic imaging method for early diagnosis of cancer.
Read the article

New ways to detect, treat cancer

New ways to detect, treat cancer

Edward Flynn could save lives with a new, ground-breaking technology intended to detect cancer much earlier than current techniques can.
Read the article

Our company

The Company's business model capitalizes on inventions and technology from which profits are created through licensing. MSI is dedicated to earning profit for its 8,600 shareholders by identifying, supporting, patenting and marketing technical innovation by harvesting top technology talent to bring game-changing product to the market.

We emphasize novel technology in the Nanomedicine space with the potential to be disruptive and the ability to establish sustainable businesses.

We are "patient capital" with experienced business building partners who bring the perspective of merchant bankers, not venture capitalists. Our approach to assist scientists to commercialize their work is by providing a forum within which the commercialization process is fostered through partnerships with existing companies (Fortune/1000 or larger). The entrepreneurial scientists and engineers who join us create personal success and wealth on an accelerated basis by virtue of ownership of publicly traded Manhattan Scientifics shares (OTC BB: MHTX).

Technology

Technology : Advenced Materials

Advanced Materials

Manhattan Scientifics has acquired the exclusive rights to the key patents and IP and will soon be positioned to enter into manufacturing and licensing agreements.

Technology : Nanomedecine

Nanomedicine

Manhattan Scientifics and Senior Scientific, LLC have announced that they have begun cooperative work to commercialize Senior Scientific's nano medicine cancer detection technology.

Latest news & media

Manhattan Scientifics Completes $2.0 Million Equity Raise

ALBUQUERQUE, N.M.--Manhattan Scientifics, Inc. has completed a $2.0 million equity raise. Details of the raise are available in the Company’s November 18th 8K filing with the SEC. The proceeds will primarily be used to fund the advancement, demonstration and validation of its MRX cancer diagnostic technology under development by its subsidiary, Senior Scientific, LLC. Full story
November 21, 2014

MHTX’s Unparalleled Cancer Measurement Technology Featured in MD Anderson Presentation

ALBUQUERQUE, N.M.--Senior Scientific LLC, a subsidiary of Manhattan Scientifics, Inc. (OTCQB: MHTX), is currently collaborating with The University of Texas MD Anderson Cancer Center (MDACC) to advance, demonstrate and validate a cancer detection and measurement technology originally developed by Edward R. Flynn, PhD. John D. Hazle, PhD of the MD Anderson Cancer Center. Full story
October 8, 2014